Truist Bumps Up Exponent's Price Target By 4%

Exponent Inc's EXPO price target has been raised to $120 (an upside of 12%) from $115 by Truist analyst Tobey Sommer after hosting the company's CEO and CFO for investor meetings.
The analyst maintained a Buy rating on the shares.
Sommer noted that the company's domestic court activity has continued to improve through the first quarter. He views Exponent's initial 2022 margin guidance as a "conservative benchmark."
The analyst expects the company to benefit from increased investment in infrastructure and energy transition measures.
Price Action: EXPO shares are trading higher by 1.99% at $107.68 on the last check Tuesday.

Momentum33.76

Growth52.20

Quality14.13

Value34.31

Short

Medium

Long

Analyst Calendar